ASP Isotopes Partners with Quantum Leap Energy and University of Bristol to Develop Advanced Laser Research Facility

ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) is accelerating its push into next-generation nuclear fuel technology with a new strategic partnership in the UK. On March 24, 2026, the Dallas-based company announced that its subsidiary, Quantum Leap Energy LLC (QLE), has teamed up with the University of Bristol to design an advanced lithium laser enrichment research facility.

This collaboration marks a key step in QLE’s broader effort to meet rapidly growing demand for advanced nuclear fuels. To begin, the University of Bristol will lead a four-month design and feasibility study. During this phase, its team will develop a full concept design, produce detailed engineering specifications, and conduct comprehensive safety assessments. Together, these efforts will establish the foundation for a potential state-of-the-art research hub.

Dr. Ryno Pretorius, CEO of Quantum Leap Energy, underscored the importance of the initiative. He explained that partnering with Bristol brings together world-class facility design expertise and deep knowledge of lithium’s role in nuclear technologies. As a result, QLE expects the project to significantly advance its mission to transform nuclear fuel production.

To execute the study, the University has assembled a multidisciplinary team. This group includes specialists in structural, mechanical, and electrical engineering, as well as experts in construction management, pyrophoric lithium handling, and laser safety. As the project progresses, the team will move through multiple development phases, ultimately reaching RIBA Stage 4, or Technical Design.

If the feasibility study delivers positive results, QLE plans to move forward with construction at an off-campus University of Bristol site. Once completed, the facility will support advanced research programs funded and commissioned by QLE.

At the same time, QLE has worked closely with UK regulators and government agencies to ensure alignment from the outset. These include the Department for Energy Security and Net Zero, the UK Atomic Energy Authority, the Office for Nuclear Regulation, and the Environment Agency. Consequently, the project reflects a strong commitment to safety, security, and regulatory compliance.

Beyond infrastructure, the partnership also reinforces QLE’s strategy of collaborating with leading academic institutions. This approach is critical as demand rises for enriched lithium isotopes. For instance, lithium-6 (⁶Li) is essential for fusion reactor breeding systems and must be enriched to levels between 60% and 90%, far above its natural abundance of about 7.5%. Meanwhile, lithium-7 (⁷Li) remains vital for both current and next-generation fission technologies.

To address these needs, QLE is leveraging its proprietary Quantum Enrichment (QE) technology. Originally developed for uranium isotope separation, QE applies quantum mechanical principles to isolate isotopes more efficiently. As a result, the technology offers meaningful advantages over traditional methods and could reshape the economics of nuclear fuel supply.

Ultimately, this initiative highlights ASP Isotopes’ broader vision. Through QLE, the company continues to expand capabilities across the nuclear fuel cycle—from uranium conversion and lithium enrichment to radioactive waste treatment. Backed by exclusive rights to its Aerodynamic Separation Process (ASP) and Quantum Enrichment technologies, and supported by partnerships with organizations such as TerraPower, Fermi America, and Necsa, the company is positioning itself to fill critical gaps in the global nuclear supply chain.

As the energy sector evolves, projects like this one signal a growing commitment to advanced nuclear solutions—and a race to secure the materials that will power them.

About Quantum Leap Energy

Quantum Leap Energy is a development-stage nuclear fuels company dedicated to advancing innovative technologies across the nuclear fuel cycle. The company focuses on both front-end activities, such as uranium conversion and isotopic separation of lithium, and back-end radioactive waste treatment technologies. With exclusive global rights to proprietary Aerodynamic Separation Process (ASP) and Quantum Enrichment (QE) technologies, QLE aims to fill critical gaps in the nuclear fuel supply chain for advanced reactors, small modular reactors, and fusion systems. Strategic partnerships with industry leaders like TerraPower, Fermi America, and Necsa further accelerate the commercialization of critical isotopes. For more information, visit www.qleapenergy.com.

About ASP Isotopes Inc.

ASP Isotopes is revolutionizing isotope enrichment with its proprietary Aerodynamic Separation Process (ASP) and Quantum Enrichment (QE) technologies. These platforms enable the production of isotopes for nuclear medicine, next-generation semiconductors, and nuclear energy. Operating enrichment facilities in Pretoria, South Africa, ASP Isotopes focuses on enriching low atomic mass elements, or light isotopes, to strengthen global supply chains. For more details, visit www.aspisotopes.com.